{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33104300",
  "DateCompleted": {
    "Year": "2021",
    "Month": "02",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "10",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.23736/S0026-4806.20.07054-8"
    ],
    "Journal": {
      "ISSN": "1827-1669",
      "JournalIssue": {
        "Volume": "112",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Feb"
        }
      },
      "Title": "Minerva medica",
      "ISOAbbreviation": "Minerva Med"
    },
    "ArticleTitle": "COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence.",
    "Pagination": {
      "StartPage": "144",
      "EndPage": "152",
      "MedlinePgn": "144-152"
    },
    "Abstract": {
      "AbstractText": [
        "The world is now entering its 9<sup>th</sup> month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus SARS-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the antivirus cell machinery by using lab-made viral mimics to engage cell receptors."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Center S.a.s., Turin, Italy - actis_g@libero.it."
          }
        ],
        "LastName": "Actis",
        "ForeName": "Giovanni C",
        "Initials": "GC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Sciences, University of Turin, Turin, Italy."
          }
        ],
        "LastName": "Ribaldone",
        "ForeName": "Davide G",
        "Initials": "DG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy."
          }
        ],
        "LastName": "Fagoonee",
        "ForeName": "Sharmila",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Gastroenterology, Molinette Hospital, Citt\u00e0 della Salute e della Scienza, Turin, Italy."
          }
        ],
        "LastName": "Pellicano",
        "ForeName": "Rinaldo",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Italy",
    "MedlineTA": "Minerva Med",
    "NlmUniqueID": "0400732",
    "ISSNLinking": "0026-4806"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interferon Inducers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Double-Stranded"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    },
    {
      "RegistryNumber": "25104-18-1",
      "NameOfSubstance": "Polylysine"
    },
    {
      "RegistryNumber": "7KYP9TKT70",
      "NameOfSubstance": "poly ICLC"
    },
    {
      "RegistryNumber": "K679OBS311",
      "NameOfSubstance": "Carboxymethylcellulose Sodium"
    },
    {
      "RegistryNumber": "O84C90HH2L",
      "NameOfSubstance": "Poly I-C"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Carboxymethylcellulose Sodium"
    },
    {
      "QualifierName": [
        "etiology"
      ],
      "DescriptorName": "Cytokine Release Syndrome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunization, Passive"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Interferon Inducers"
    },
    {
      "QualifierName": [
        "etiology"
      ],
      "DescriptorName": "Mucocutaneous Lymph Node Syndrome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Physical Distancing"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Poly I-C"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Polylysine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Guidelines as Topic"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "RNA, Double-Stranded"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Recurrence"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Secondary Prevention"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Serotherapy"
    }
  ]
}